• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    ACI Prepares for a Busy Second Half of 2022

    Honeywell Technology Boosts Efficiency And Reduces Carbon Footprints

    Protection & Correction: Facial Cosmetics

    Preservatives Market Expands to Maintain Longevity & Quality in Household & Personal Care

    Advancing the Research in Preservation Science
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    Toning Collection For Zero-Brass Blondes is New at Colorproof

    Esthetician Studio Beauty Concepts Files Trademark Infringement Lawsuit Against Kim Kardashian and Coty, Inc.

    Joy Liquid Dishwash Brand Expands Into Auto Dish Market

    Parfums Christian Dior Launches Sustainability Program

    Mary Kay Awarded New Skin Care Patent
    Blog
    Online Exclusives
    Glossary
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    HappiTV
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    13. Boticario

    Procter & Gamble

    35. Combe Inc.

    31. Inter Parfums

    Avon
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    ACI Prepares for a Busy Second Half of 2022

    Honeywell Technology Boosts Efficiency And Reduces Carbon Footprints

    Protection & Correction: Facial Cosmetics

    Preservatives Market Expands to Maintain Longevity & Quality in Household & Personal Care

    Advancing the Research in Preservation Science
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    Toning Collection For Zero-Brass Blondes is New at Colorproof

    Esthetician Studio Beauty Concepts Files Trademark Infringement Lawsuit Against Kim Kardashian and Coty, Inc.

    ACI Prepares for a Busy Second Half of 2022

    Joy Liquid Dishwash Brand Expands Into Auto Dish Market

    Protection & Correction: Facial Cosmetics
    Lab Equipment
    Mixing
    Packaging
    Testing

    L’Oréal Paris Has a New Answer For Men with Gray Hair

    Labskin's Microbiome-Friendly+ Seal of Approval Available in the US

    Sustainability Continues To Shape Beauty, Home & Personal Care Packaging

    Technology Cuts Plastic Decomposition from 500 Years to Three Months

    Aerosol Recycling Initiative Launched by HCPA
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    Jeen International

    LipoTrue Inc.

    BotanicalsPlus

    Croda Inc

    KLK OLEO
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Glossary
    • Experts Opinion
    • Slideshows
    • HappiTV
    • Podcasts
    • Videos
    • Infographics
    • eBook
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    CBD Safety Assessment

    A flood of all types of consumer products in the marketplace warrants a review of available scientific evidence.

    CBD Safety Assessment
    By Marilyn Barrett, PhD, Pharmacognosy Consulting, Inc., Mary Ellen Cosenza, PhD, MEC Regulatory & Toxicology Consulting, Steven Dentali, PhD, Dentali Botanical Sciences, and Sandy Bigelow, PhD, Vanguard Global Associates LLC04.10.20
    Significant public interest and consumer acceptance of cannabidiol (CBD) over the last 2-3 years has created a burgeoning marketplace with estimated sales last year of $5 billion. It cannot be denied that products purporting to contain CBD are pervasive.

    CBD is a terpenoid-phenolic compound, one of a class of compounds called cannabinoids that are produced in the resinous hairs (glandular trichomes) of Cannabis sativa L. The group of 20-plus major cannabinoids includes other cannabinoids such as Δ9-tetrahydrocannabinol (THC), its degradation product cannabinol, cannabigerol, cannabichromene and tetrahydrocannabivarin. THC produces psychogenic effects that may be associated with habitual use via regular cannabis smoking or ingestion of edibles. CBD has been found not to exert psychogenic effects and not to promote habitual use, thus exhibiting a limited potential for abuse.

    Regulatory Matters

    Until recently, all products made from cannabis were categorized as schedule I drugs, as per the Controlled Substances Act of 1970 (21 USC §801). Schedule I drugs are substances with no currently accepted medical use and a high potential for abuse. The Farm Bill enacted in December 2018 removed hemp from Schedule I controlled substances, making it an ordinary agricultural commodity. Hemp is defined as cannabis with not more than 0.3% of THC. The passage of the 2018 Farm Bill led many people to believe that CBD could be sold legally as a dietary supplement.

    In 1985, the Food and Drug Administration (FDA) approved two synthetic (not found in nature) cannabinoid-based drugs—dronabidol and nabilone—for use in a variety of indications including treatment of pain; they appear to be used as alternatives to opiates in relieving pain and for treating nausea in patients undergoing chemotherapy. In June of 2018, the FDA approved a CBD product, Epidiolex, to be marketed as a drug for the treatment of seizures associated with Lennox-Gastaut or Dravet syndromes in patients two years of age and older.

    Because CBD was first publicly investigated as a drug, the FDA concluded that it may not be legally sold as an ingredient in dietary supplements; the Dietary Supplement Health and Education Act (DSHEA) excludes such materials by definition. To further complicate the issue, individual states have passed their own laws pertaining to cannabis and CBD that contradict the federal position.

    Product Profiles

    This regulatory conundrum has not presented a roadblock to the explosion of sales of CBD products in the U.S. Numerous CBD-containing products are sold as foods, cosmetics and dietary supplements in the U.S. marketplace. Foods containing CBD include flavored waters and beer. Topical CBD products include creams, sprays and salves. Dietary supplement CBD products include tinctures, extracts and oils, capsules, pills and gummies. CBD is also often taken via inhalation by smoking cannabis and in vaping products. All of these products are taken by consumers with the hope of treatment for ailments such as joint pain, back pain, muscle soreness, headache, occasional sleeplessness, anxiety or stress. CBD products for pet use are also emerging in the marketplace.

    Some products contain purified CBD as an isolated compound, while others contain tinctures or extracts with CBD in a matrix of other compounds—either naturally present in the cannabis plant like other cannabinoids, terpenes and flavonoids, or additional ingredients not present in cannabis but thought to enhance the activity of CBD.

    Safety Analysis

    This escalation of products into the marketplace begs consideration of the question of consumer safety. Safety reviews of products in the public domain proceed in a systematic manner. In this process, the scientific literature is reviewed for indications of potential hazards. Highest priority is placed on adverse effects reported in humans, in descending order from clinical trials and observational studies, to case reports and anecdotal evidence. Toxicologists examine the literature to determine if a causal relationship to reported adverse events can be determined. They ask if the event was observed after the product was taken, how consistent this effect is, if there is a dose-related effect, and if the adverse event is biologically plausible according to biochemical and pharmacological information.

    Most toxicological evidence used in risk assessments come from animal studies. Doses much higher than consumed by humans are used to reveal any possible toxic responses in animals. Once results from these studies are gathered, considerations are made for possible species differences in metabolism and pharmacology between the animals and humans. Considerations are given to sensitive subpopulations that might have responses (in terms of incidence, severity or both) that are different from the responses expected for the healthy population.

    An important preliminary step in any safety evaluation is consideration of the absorption of the ingredient into the body. Factors that affect absorption and the ingredient’s action in the body include its concentration and chemical form, the nutrition and health of the individual, and the process of metabolizing and excreting the ingredient via urine and feces.

    Reports show that CBD is a fat-soluble compound that exhibits limited bioavailability (absorption from the gut into the body) after oral use. Oral ingestion of 20 mg CBD by humans leads to maximal plasma CBD levels within two hours of initial exposure and a plasma half-life of about two hours. Ingesting CBD with fatty foods delays absorption from the gastrointestinal tract, yet once absorbed leads to higher plasma levels.

    The literature identifies three possible areas of concern: the risk of liver damage, the risk of reproductive impairment and the potential for CBD-drug interactions. The first concern is derived from clinical findings with Epidiolex, which showed that oral CBD ingestion caused mild dose-dependent elevations in serum liver enzyme levels. Elevation of serum liver enzymes was also observed in several animal studies following intake of various preparations of CBD. However, these concerns did not meet the criteria for drug-induced liver toxicity as there was no concurrent elevation of blood levels of bilirubin, a reddish-yellow pigment made during the normal breakdown of hemoglobin in red blood cells. In other words, there was no evidence of jaundice and there was no change in blood coagulation. The identified risks for elevation of liver enzymes following intake of CBD were identified with higher doses, already elevated levels of these enzymes (liver dysfunction) and taking another seizure medication.

    The second concern from toxicological studies conducted in animals indicate potential detrimental effects on reproductive health as a decrease in sperm production in monkeys and mice. In contrast, the FDA review of studies conducted with Epidiolex concluded no effects on male or female rodent reproductive indices. However, the FDA is concerned about the lack of safety information on CBD regarding reproductive health and has released a caution against the use of CBD in supplements by pregnant or breastfeeding women. More studies are warranted, but as pregnant and breastfeeding women are especially sensitive, caution is advised.

    Lastly, there is a concern that CBD might alter the concentration levels of certain medicines in the body. CBD is reported to be a broad-spectrum but weak inhibitor of some enzymes in the liver (cytochrome P-450 enzymes) which might alter the way that other drugs are metabolized. So far, studies conducted in humans have only explored the combination of the drug Epidiolex with other anti-seizure medications. The significance of these findings to potential interactions between more common medicinal agents with CBD has not been determined clinically. Clinical studies in humans will need to be conducted to address this drug interaction potential more fully.

    In summary, the evidence suggests that healthy adults are unlikely to exhibit liver problems following CBD ingestion. However, it may be unwise for those with symptoms of liver disease to take CBD. Symptoms of liver disease can vary, but they often include swelling of the abdomen and legs, bruising easily, dark color stools and urine, and yellowing of the skin and eyes. It is prudent for those women and men planning on a pregnancy, and women who are pregnant or breastfeeding, to limit their CBD ingestion or avoid it altogether. Finally, those currently on medications should seek advice from their healthcare professional before taking CBD products. Consumers should also be mindful of CBD dosage and resist combining multiple sources of CBD in one day.
    Related Searches
    • it
    • men
    • regulatory
    • color
    Related Knowledge Center
    • Functional Ingredients
    • Actives

    Related Content

      Loading, Please Wait..
      Trending
      • Succeeding In Skin Care
      • L’Oréal's New UVMune 400 Sun Filtering Technology Protects Skin From Ultra-Long UVA Rays
      • Boots, No7 Beauty Brand Are No Longer For Sale
      • Parfums Christian Dior Launches Sustainability Program
      • La Roche-Posay Takes Oily Skin To The Matte With Latest Double Repair Moisturizer
      Breaking News
      • Toning Collection For Zero-Brass Blondes is New at Colorproof
      • Esthetician Studio Beauty Concepts Files Trademark Infringement Lawsuit Against Kim Kardashian and Coty, Inc.
      • Joy Liquid Dishwash Brand Expands Into Auto Dish Market
      • Parfums Christian Dior Launches Sustainability Program
      • Mary Kay Awarded New Skin Care Patent
      View Breaking News >
      CURRENT ISSUE

      July 2022

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Pharmavite Expands in Ohio with $200 Million Investment
      Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
      Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
      Coatings World

      Latest Breaking News From Coatings World

      Azelis Acquires Chemical Partners, Strengthens Leadership in Africa and Middle East
      Emmanuelle Bromet Named Arkema Sustainable Development VP
      ROSS Planetary Dual Dispersers Have Unique Processing Flexibility
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser
      Pancryos Forges License Agreement for Microencapsulation Device
      FDA Awards IDE Approval to SELUTION SLR Drug-Eluting Balloon
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Bayer Opens New Research and Innovation Center at Kendall Square
      Lonza Names Maria Soler Nunez as Head, Group Operations
      Eurofins DiscoverX Opens Shanghai Office
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Dexlevo Introduces Beauty Treatment technique, ‘GOURI’
      Revision Skincare Exec Wins Ernst & Young Entrepreneur of the Year
      Latest Updates About Cosmoprof North America
      Happi

      Latest Breaking News From Happi

      Toning Collection For Zero-Brass Blondes is New at Colorproof
      Esthetician Studio Beauty Concepts Files Trademark Infringement Lawsuit Against Kim Kardashian and Coty, Inc.
      Joy Liquid Dishwash Brand Expands Into Auto Dish Market
      Ink World

      Latest Breaking News From Ink World

      Azelis Acquires Chemical Partners, Adds to Leadership in Africa and Middle East
      International Paper Publishes 2021 Sustainability Report
      Epson Now Shipping New SureColor P8570D 44-Inch Production Photo and Graphics Printer
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      UPM Raflatac boosts operations in US, All4Labels returns to HP and more
      Fedrigoni Self-Adhesives to exhibit at Labelexpo Americas for first time
      CELAB Europe wins Paper Recycling award
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Glatfelter, Blue Ocean Closures Partner with Absolut
      What You’re Reading on Nonwovens-Industry.com
      Daio, Livedo Partner to Recycle Diapers
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      NuVasive Inc. Opens Singapore Experience Center
      Pedicle Screw Systems Market to Top $3B in 2027
      3Spine Completes First U.S. Surgeries in IDE Pivotal Clinical Trial
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Epishine is Building a New Solar Cell Factory in Linköping, Sweden
      Toppan Establishes CVC Fund and Investment Management Company in the US
      EU-Consortium FlexFunction2Sustain Creates World’s First OPV Cell on Recycled Material

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login